Allucent Executive and Leadership Team

October, 2026

Leadership Overview

Allucent has 5 executives leading key functions including strategy, information technology, marketing, product development, and clinical trial operations.

Focused on accelerating global drug development, Allucent delivers comprehensive research solutions through an individualized partnership model that brings novel treatments to patients across more than 60 countries.

Leadership Roles at Allucent

  • Chief Executive Officer - Paula Stafford
  • President, Product Development Strategy - Leslie Devos
  • President, Clinical Trial Operations - Anita Nelsen
  • Chief Information Officer - Nathan Thompson
  • Chief Marketing Officer - Steffany Cox
  • Paula Stafford - Chief Executive Officer

    Paula Stafford, the Chief Executive Officer at Allucent, directs the overarching corporate strategy and global vision for the organization. By aligning internal resources with the complex demands of drug development, the Chief Executive Officer ensures that the company maintains a competitive edge across diverse therapeutic areas. Stafford oversees the integration of various service providers into a unified, high-performance entity capable of navigating international regulatory landscapes. This leadership role involves constant collaboration with the Board to drive long-term growth and operational excellence. Through the implementation of individualized partnership models, Paula Stafford fosters deep client relationships that translate into successful clinical outcomes. Ultimately, the Chief Executive Officer secures the firm's position as a premier partner for pharmaceutical innovators seeking to deliver life-saving treatments to patients worldwide, while simultaneously managing the complexities of operations spanning over 60 countries.

    Leslie Devos - President, Product Development Strategy

    Leslie Devos, the President, Product Development Strategy at Allucent, architects the scientific frameworks and strategic roadmaps for client drug development programs. By providing experience-driven insights, the President, Product Development Strategy ensures that clinical pathways are optimized for success from early-stage research through regulatory approval. Devos oversees the design of complex development plans that address the unique needs of various therapeutic areas, ensuring alignment with global standards. This leadership role involves guiding cross-functional teams to navigate the intricacies of novel treatment delivery. Leslie Devos collaborates with the executive leadership to refine the company's service offerings, ensuring that the firm remains at the forefront of scientific innovation. By focusing on strategic planning and technical excellence, the President, Product Development Strategy directly impacts the speed and efficiency with which clients bring new therapies to patients, ultimately strengthening the company's reputation for high-quality research outcomes.
    Leslie Devos

    Anita Nelsen - President, Clinical Trial Operations

    Anita Nelsen, the President, Clinical Trial Operations at Allucent, executes the day-to-day management of global clinical research activities. By overseeing the implementation of trial protocols across more than 60 countries, the President, Clinical Trial Operations ensures that all studies meet rigorous quality and compliance standards. Nelsen directs the operational teams responsible for site management, patient recruitment, and data collection, ensuring that every project remains on schedule and within scope. This leadership role involves constant coordination with internal departments to resolve logistical challenges and maintain high performance levels. Anita Nelsen drives the operational excellence required to support the company's mission of delivering novel treatments to patients in need. By optimizing resource allocation and streamlining trial processes, the President, Clinical Trial Operations facilitates the successful execution of complex research programs, directly contributing to the firm's ability to provide reliable, high-quality clinical development solutions to a global client base.

    Nathan Thompson - Chief Information Officer

    Nathan Thompson, the Chief Information Officer at Allucent, architects the digital infrastructure necessary to support global drug development operations. By deploying advanced data management systems, the Chief Information Officer ensures the security and integrity of clinical trial information across all 60 countries of operation. Thompson drives the digital transformation agenda, integrating cutting-edge technology into the company's research workflows to enhance efficiency and data-driven decision-making. This leadership role involves close coordination with the executive team to align technical capabilities with the broader business mission of delivering novel treatments. Nathan Thompson optimizes internal platforms to facilitate seamless collaboration between global teams and external partners. By prioritizing scalable cloud solutions and robust cybersecurity, the Chief Information Officer protects the intellectual property of clients while maintaining the high standards required for complex, multi-phase clinical research projects.
    Nathan Thompson

    Steffany Cox - Chief Marketing Officer

    Steffany Cox, the Chief Marketing Officer at Allucent, drives the global brand strategy and market positioning for the organization. By articulating the value of the company's comprehensive drug development solutions, the Chief Marketing Officer ensures that the firm remains the preferred partner for pharmaceutical innovators. Cox oversees all external communications, digital presence, and industry engagement initiatives to expand the company's footprint across diverse therapeutic markets. This leadership role involves crafting compelling narratives that highlight the firm's 30 years of experience and individualized partnership approach. Steffany Cox collaborates with the executive team to translate complex research capabilities into clear, actionable market insights that resonate with global clients. By analyzing market trends and competitive dynamics, the Chief Marketing Officer shapes the long-term growth trajectory of the business, ensuring that the brand effectively communicates the impact of its work on patient health outcomes.
    Steffany Cox

    Explore Leadership Teams in Business Services

    Frequently Asked Questions Regarding Allucent Top Executives and Leadership Team

    Who leads Allucent?
    Allucent is led by Paula Stafford (Chief Executive Officer), along with executives such as Leslie Devos (President, Product Development Strategy) and Anita Nelsen (President, Clinical Trial Operations).
    Who is part of Allucent’s executive team?
    The executive team of Allucent includes leaders such as Paula Stafford (Chief Executive Officer), Leslie Devos (President, Product Development Strategy), Anita Nelsen (President, Clinical Trial Operations) and other senior executives.
    How many executives does Allucent have?
    Allucent has 5 executives leading key business areas.
    What roles are included in Allucent’s leadership team?
    The leadership team of Allucent includes roles such as Chief Executive Officer, President, Product Development Strategy, President, Clinical Trial Operations, Chief Information Officer, Chief Marketing Officer.